These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 12082617)
1. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617 [TBL] [Abstract][Full Text] [Related]
2. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
3. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563 [TBL] [Abstract][Full Text] [Related]
4. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
5. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
6. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related]
7. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cerny WL; Mangold KA; Scarpelli DG Cancer Res; 1992 Aug; 52(16):4507-13. PubMed ID: 1643642 [TBL] [Abstract][Full Text] [Related]
8. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
9. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma. Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168 [TBL] [Abstract][Full Text] [Related]
10. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574 [TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
14. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989 [TBL] [Abstract][Full Text] [Related]
15. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992 [TBL] [Abstract][Full Text] [Related]
16. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. Minamoto T; Mai M; Ronai Z Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118 [TBL] [Abstract][Full Text] [Related]
17. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation. Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750 [TBL] [Abstract][Full Text] [Related]
18. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer]. Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160 [TBL] [Abstract][Full Text] [Related]
19. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue]. Cui Q; Wang Z; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165 [TBL] [Abstract][Full Text] [Related]
20. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing. Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]